FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to gastroenterology, and can be used for prevention of complications in patients with nonspecific ulcerative colitis. Method involves standard drug therapy and ozone therapy. Latter is performed by injections of 6 ml of ozonized autoblood at 1 ml in twin points V29, E36 and F8 daily for 10 days.
EFFECT: method provides effective treatment of aggravation and stable remission of disease.
1 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PATIENTS FOR NONSPECIFIC ULCERATING COLITIS | 1999 |
|
RU2200007C2 |
| METHOD FOR INTRAPERITONEAL APPLICATION OF MEDICAL OZONE FOR TREATING ULCERATIVE COLITIS | 2021 |
|
RU2782488C1 |
| METHOD FOR TREATING PATIENTS WITH GASTRIC ULCER ASSOCIATED WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) | 2019 |
|
RU2723457C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH EXACERBATION OF CHRONIC NONCALCULOLIS CHOLECYSTITIS | 2015 |
|
RU2638643C2 |
| DIAGNOSTIC TECHNIQUE FOR AGGRAVATION OF NON-SPECIFIC ULCERATIVE COLITIS IN CHILDREN | 2011 |
|
RU2467333C1 |
| METHOD FOR REHABILITATION OF PATIENTS WITH ALCOHOL POLYNEUROPATHY | 2015 |
|
RU2594252C1 |
| METHOD OF TREATING GASTRODUODENAL ULCER | 2014 |
|
RU2570343C1 |
| METHOD TO TREAT DUODENAL ULCERS | 1999 |
|
RU2177790C2 |
| METHOD FOR EVALUATING OZONE THERAPY EFFECTIVENESS IN PATIENTS POSSESSING CHELICOBACTER DISEASE | 1999 |
|
RU2155344C1 |
| THERAPY METHOD FOR SLUGGISH ULCERS AND EROSIONS IN GASTRODUODENAL SYSTEM | 2003 |
|
RU2261091C2 |
